Michael Mischke-Reeds has served as Senior Vice President of Strategy and Portfolio since September 2021. Prior to joining Nurix, Mr. Mischke-Reeds was co-founder and Managing Partner of Keelin Reeds Partners, a management consulting firm that has provided valuation, strategy, portfolio and transaction support services to the biotech industry since 2003. Mr. Mischke-Reeds’ consulting career began at Strategic Decisions Group, a world leader in pharmaceutical asset valuation and portfolio management. In addition to consulting roles, Mr. Mischke-Reeds has held executive positions as Senior Vice President of Business Development at EMulate Therapeutics, as co-founder and Vice President of Operations at Fast Track Systems, and as co-founder and Head of Product Development at Chiron Informatics. Mr. Mischke-Reeds holds a B.A. from Stanford University and an M.A. from Naropa University.